comparemela.com

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)

tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Temple University , Pennsylvania , United States , Bucks County , New Jersey , Philadelphia , Louie Toma , Kannalifea Neuropathix , Douglas Brenneman , Mark Mcdonnell , Doug Brenneman , Temple University Center , Ready The Company To Begin , Pennsylvania Biotechnology Center , Company Twitter , Lewis Katz School Of Medicine , Initiative Helping End Addiction , Development Of Therapies , Kannalife Sciences Inc , National Institute Of Neurological Disorders , National Institute , Neuropathix Inc , Substance Abuse Research , Assets Include Company Non , National Institutes Of Health , Temple University Conflict Of Interest , Drug Administration , Preclinical Screening Program For Pain , Company Strategy , Hepatitisb Foundation , Blumberg Institute , Baruchs Blumberg Institute , Securities Exchange , Katz School Of Medicine , Pharmaceutical Assets Include Company , Non Opioid Anti Inflammatory Compound , Grant Funds , Complete Preclinical Studies , Kannalife Sciences , Neurological Disorders , National Institutes , Helping End Addiction Long Term , Technologies Directed , Enhanced Pain Management , Chief Pharmacologist , Sara Jane Ward , Assistant Professor , Katz School , Preclinical Screening Program , Bill Kinney , Lewis Katz School , Dean Petkanas , Neural Sciences , Global Neuropathic Pain , Global Opioids Drug , Philadelphia New Jersey , Securities Act , Securities Exchange Act , Safe Harbor , United States Controlled Substances ,

comparemela.com © 2020. All Rights Reserved.